CEO SUMMARY: With public interest in home testing growing, some IVD manufacturers are preparing to serve a fast-expanding market for over-the-counter and at-home tests. IVD firms are banking on the idea that consumers—at the first sign of symptoms—will want a self-administered respiratory illness test either at home or easily available at a local pharmacy. SOME […]
IVD Firms Prepare for OTC, Home Test Market Expansion
Expert weighs in on what factors drive demand for testing outside traditional collection centers
- By Robert Michel
- > From the Volume XXX, No. 6 - April 17, 2023 Issue
- Tags: Abbott BinaxNOW, at-home-test, BD, Becton Dickinson, Bruce Carlson, COVID-19, COVID-19 and Flu Home Test, Douglas Bryant, EUA, FDA Center for Devices and Radiological Health, FDA Emergency Use Authorization (EUA), FDA-cleared test, Flu A, Flu B, Food and Drug Administration, Group A Strep, in vitro diagnostics, Influenza, IVD, ivd/lab informatics, Jeffrey Shuren MD JD, Kalorama Information, LabCorp, Labcorp OnDemand, Lucira Health, NBC News, OrthoClinical Diagnostics, over-the-counter test, POC, point-of-care, Quest Diagnostics, QuidelOrtho, rapid testing, Raymond James, RegisteredNursing.org, Robert Ford, RSV, RSV PCR test, SARS-CoV-2 rapid antigen test, Science and Medicine Group, Sekisui Diagnostics, Sofia, Susan Butler-Wu PhD, Syncytial Virus, the dark report, University of Southern California
